Sergify MedicalAn Espu-based Medtech company, his surgical is focusing on the protection of bone surgical protection and accuracy with technology, and the success of the fund has collected 7 million with the success of the fund.
The round of the fund was led by the corporate Venture Arm Ventaches of the Carl Jis Group, with the participation of the European Innovation Council Fund (EIC Fund). Existing investors from Sergify, including Lednil and Cascara Ventures, also participated in financing.
“Jis brings surgical technology and unparalleled experience on a global network, while the continued support of EIC and previous grant financing refers to the confidence of European innovative ecosystem towards our solution,“Said Visa CippolaSergify Medical Co-founder and CEO. “With the approval of these funds and regulatory in both the EU and the United States we are in better position to bring our unique technology internationally to more surgeons and patientsThe “
Established in 2017, the SurgiFi Medical is dedicated to the invention of bone surgical, faster and more precisely. The company’s flagship products, surgeify hello, strict and soft tissues are designed to distinguish between the strict and soft tissues, which are reported to provide an increased protection against the incidental soft tissue damage and streamlining method.
The benefits of Sergify Hallo are extended beyond the main market for head, neck and spinal surgery. Surgify technology is also likely to affect the growing field of robotic surgery by enable reliable automatic bone resctions.
With investment, the agency plans to take the next step towards being a multi-billion-e-Euro market for bone surgical devices. Based on a successful Nordic Market launch, the company will expand its activities in the EU and the United States, where Sergifai says that the original hospitals have already started adopting the technology.
“Sergifai technology is a major progress in today’s developed healthcare landscape. SergiFi Hello has already left an important footprint in the field, with the process“Said Alan Rofnes PergerChairman of Sergify Medical.
According to the agency, conventional surgical drills spin a few thousand times per minute and if they come into contact with critical soft tissues, it can be dangerous. Badly, this national soft tissue damage can lead to serious injury to the patient. Soft tissue injuries are considered as a highly relevant surgical complication in various types of head, neck and spinal cords associated with bone re-construction, and this leads to more than $ 4 billion at the cost of global annual complications.
Sergify is reported to have cut bones while providing unique protective power against incidental injuries in soft tissues such as the central nervous system structure, blood vessels and nerves. The technology is said to provide effective bone redishes together with a soft tissue protection feature for increased protection and accuracy in the surgical system.
“We are interested in partnering with Surgifai in their mission to establish a new criterion for surgical protection. Surgief is the Bars Traditional Burses provides exceptional control of comparable rates, while at the same time secures subtle soft tissues. This is the Barse Switch that makes an obvious choice for surgeons“Explained Dr. Boris HoffmanJis is the head of the Venture. “We are eager to support the team as they extend their solutions worldwideThe “
To date, SurgiFi has collected $ 1 million for the medical funds and has offices in Finland, Sweden, Denmark and the United States.
[publish_date
